Mr. Geir Gogstad serves as Chief Executive Officer of Genpoint AS. Mr. Gogstad has been engaged with Start Fondet since March 2001. He served as R&D Director at Axis-Shield plc, and has previously held similar positions at Nycomed ASA (presently Amersham Health). Mr. Gogstad has 18 years of experience as head of industrial R&D related to diagnostics and therapeutics. Mr. Gogstad holds a Ph.D. from UiO within the blood coagulation stream.